HUE044329T2 - Iota-karragént tartalmazó készítmény vírusos kötõhártya-gyulladás ellen - Google Patents

Iota-karragént tartalmazó készítmény vírusos kötõhártya-gyulladás ellen

Info

Publication number
HUE044329T2
HUE044329T2 HUE14152188A HUE044329T2 HU E044329 T2 HUE044329 T2 HU E044329T2 HU E14152188 A HUE14152188 A HU E14152188A HU E044329 T2 HUE044329 T2 HU E044329T2
Authority
HU
Hungary
Prior art keywords
iota
composition
against viral
viral conjunctivitis
carrageenan against
Prior art date
Application number
Other languages
English (en)
Inventor
Eva Prieschl-Grassauer
Martina Morokutti-Kurz
Andreas Grassauer
Sabine Nakowitsch
Angelika Bodenteich
Marielle Koenig-Schuster
Christiane Koller
Original Assignee
Visufarma B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Visufarma B V filed Critical Visufarma B V
Publication of HUE044329T2 publication Critical patent/HUE044329T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731Carrageenans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
HUE14152188 2014-01-22 2014-01-22 Iota-karragént tartalmazó készítmény vírusos kötõhártya-gyulladás ellen HUE044329T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14152188.0A EP2898888B8 (en) 2014-01-22 2014-01-22 Composition comprising iota-carrageenan against viral Conjunctivitis

Publications (1)

Publication Number Publication Date
HUE044329T2 true HUE044329T2 (hu) 2019-10-28

Family

ID=49956098

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14152188 HUE044329T2 (hu) 2014-01-22 2014-01-22 Iota-karragént tartalmazó készítmény vírusos kötõhártya-gyulladás ellen

Country Status (15)

Country Link
US (1) US10220055B2 (hu)
EP (2) EP2898888B8 (hu)
JP (1) JP6635343B2 (hu)
CN (1) CN105939720B (hu)
CA (1) CA2937402C (hu)
DK (1) DK2898888T3 (hu)
ES (2) ES2734269T3 (hu)
HR (1) HRP20191050T1 (hu)
HU (1) HUE044329T2 (hu)
MX (1) MX2016009475A (hu)
PL (1) PL2898888T3 (hu)
PT (1) PT2898888T (hu)
RS (1) RS58731B1 (hu)
SI (1) SI2898888T1 (hu)
WO (2) WO2015110429A1 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6794454B2 (ja) * 2015-09-25 2020-12-02 オコジェン、インコーポレイテッドOkogen, Inc. ランピルナーゼおよび/またはアンフィナーゼを使用するウイルス性結膜炎の処置

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783446A (en) * 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses
FR2653021A1 (fr) * 1989-10-17 1991-04-19 Merck Sharp & Dohme Composition ophtalmique aqueuse liquide a transition de phase liquide-gel.
EP0495421B1 (en) * 1991-01-15 1996-08-21 Alcon Laboratories, Inc. Use of carrageenans in topical ophthalmic compositions
IT1313610B1 (it) * 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
AR031135A1 (es) * 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
DE10352137A1 (de) 2003-11-04 2005-06-16 Beschorner, Katharina, Dr. Verwendung sulfatierter Hyaluronsäure
DE102005046769A1 (de) 2005-09-29 2007-04-05 Berlin-Chemie Ag Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus)
CA2651868C (en) * 2006-05-13 2014-11-25 Lg Electronics Inc. Method of performing procedures for initial network entry and handover in a broadband wireless access system
DE602007005697D1 (de) * 2006-12-05 2010-05-12 Marinomed Biotechnologie Gmbh Verwendung von carrageenan zur behandlung von rhinovirus-infektionen
CA2696009C (en) 2007-08-24 2016-08-02 Marinomed Biotechnologie Gmbh Antiviral composition comprising a sulfated polysaccharide
US9481856B2 (en) 2008-06-09 2016-11-01 Bausch & Lomb Incorporated Pharmaceutical formulations comprising stabilized polysaccharides and source of hydrogen peroxide
CN102065869B (zh) * 2008-07-01 2014-10-08 玛丽诺姆德生物技术公司 抗过敏的海洋生物聚合物
US20100086512A1 (en) 2008-10-02 2010-04-08 Rolf Schaefer Mucomimetic compositions and uses therefore
SG181421A1 (en) * 2009-12-22 2012-07-30 Marinomed Biotechnologie Gmbh Synergistic antiviral composition and use thereof
WO2012000055A1 (en) * 2010-07-02 2012-01-05 Brien Holden Vision Institute Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
CN102988280B (zh) * 2012-10-08 2014-03-19 新乡医学院 一种加雷沙星滴眼剂

Also Published As

Publication number Publication date
WO2015110429A1 (en) 2015-07-30
EP2898888B1 (en) 2019-04-24
EP2898888B8 (en) 2019-06-12
MX2016009475A (es) 2017-01-16
SI2898888T1 (sl) 2019-06-28
EP3096766A1 (en) 2016-11-30
PT2898888T (pt) 2019-07-16
CA2937402A1 (en) 2015-07-30
JP2017503841A (ja) 2017-02-02
WO2015110430A1 (en) 2015-07-30
PL2898888T3 (pl) 2019-09-30
US20160331776A1 (en) 2016-11-17
ES2734269T3 (es) 2019-12-05
DK2898888T3 (da) 2019-06-03
EP2898888A1 (en) 2015-07-29
CN105939720B (zh) 2020-01-31
ES2791360T3 (es) 2020-11-04
RS58731B1 (sr) 2019-06-28
HRP20191050T1 (hr) 2019-09-06
EP3096766B1 (en) 2020-02-26
JP6635343B2 (ja) 2020-01-22
US10220055B2 (en) 2019-03-05
CA2937402C (en) 2022-07-12
CN105939720A (zh) 2016-09-14

Similar Documents

Publication Publication Date Title
PL3234071T3 (pl) Piec
HK1214967A1 (zh) 組合物
SG11201704735WA (en) Composition
HK1218859A1 (zh) 組合物
ZA201702830B (en) Brazing sheet
GB201403017D0 (en) Composition
GB201402169D0 (en) Viral inhibitors
SG10201507112YA (en) Furnace
HK1244432A1 (zh) 組合物
GB201414910D0 (en) Composition
ZA201704464B (en) Composition
GB201403561D0 (en) Composition
GB201414555D0 (en) Composition
GB201410493D0 (en) Composition
GB2530668B (en) Stove
GB201519442D0 (en) Composition
ZA201606127B (en) Composition
SI2898888T1 (sl) Sestavek, ki obsega iota-karagenan, proti virusnemu konjunktivitisu
GB201420628D0 (en) Composition
GB201415483D0 (en) Composition
GB201404390D0 (en) Composition
GB201402648D0 (en) Composition
IL250781A0 (en) preparation
GB201503484D0 (en) Composition
GB201502355D0 (en) Composition